JPY4,315.00
1.55% today
Tokyo, Aug 07, 08:15 am CET
ISIN
JP3160400002
Symbol
4523
Index

Eisai Stock price

JPY4,249.00
+205.00 5.07% 1M
-252.00 5.60% 6M
-80.00 1.85% YTD
-998.00 19.02% 1Y
-1,863.00 30.48% 3Y
-4,289.00 50.23% 5Y
-4,235.00 49.92% 10Y
+419.00 10.94% 20Y
Tokyo, Closing price Wed, Aug 06 2025
-70.00 1.62%
ISIN
JP3160400002
Symbol
4523
Index
Industry

Key metrics

Basic
Market capitalization
JPY1.2t
Enterprise Value
JPY1.1t
Net debt
positive
Cash
JPY266.0b
Shares outstanding
282.1m
Valuation (TTM | estimate)
P/E
25.8 | 23.5
P/S
1.5 | 1.5
EV/Sales
1.4 | 1.4
EV/FCF
159.3
P/B
1.5
Dividends
DPS
JPY160.00
Yield 1Y | 5Y
3.8% | 2.4%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
97.7% | 95.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
JPY789.4b | JPY800.2b
EBITDA
JPY94.3b | JPY102.5b
EBIT
JPY54.4b | JPY71.2b
Net Income
JPY46.4b | JPY51.9b
Free Cash Flow
JPY7.1b
Growth (TTM | estimate)
Revenue
6.4% | 1.4%
EBITDA
-0.9% | 8.7%
EBIT
-2.5% | 31.0%
Net Income
9.5% | 11.7%
Free Cash Flow
-77.1%
Margin (TTM | estimate)
Gross
78.6%
EBITDA
11.9% | 12.8%
EBIT
6.9%
Net
5.9% | 6.5%
Free Cash Flow
0.9%
Financial Health
Equity Ratio
60.7%
Return on Equity
5.5%
ROCE
5.4%
ROIC
5.1%
Debt/Equity
0.2
More
EPS
JPY164.6
FCF per Share
JPY25.3
Short interest
-
Employees
11k
Rev per Employee
JPY71.3m
Show more

Is Eisai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Eisai Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Eisai forecast:

8x Buy
44%
9x Hold
50%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Eisai forecast:

Buy
44%
Hold
50%
Sell
6%

Financial data from Eisai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
789,400 789,400
6% 6%
100%
- Direct Costs 168,807 168,807
9% 9%
21%
620,593 620,593
6% 6%
79%
- Selling and Administrative Expenses 407,983 407,983
9% 9%
52%
- Research and Development Expense 171,633 171,633
3% 3%
22%
94,284 94,284
1% 1%
12%
- Depreciation and Amortization 39,906 39,906
1% 1%
5%
EBIT (Operating Income) EBIT 54,378 54,378
2% 2%
7%
Net Profit 46,432 46,432
9% 9%
6%

In millions JPY.

Don't miss a Thing! We will send you all news about Eisai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Haruo Naito
Employees 11,067
Founded 1936
Website www.eisai.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today